Better Bugs as Drugs: The Digest’s 2019 Multi-Slide Guide to SCIBAC

April 28, 2019 |

SCIBAC has developed a patented MERGE (Microbial Enhanced Recombinants Generated by Evolution) platform for strain improvement works by harnessing and directing a natural evolutionary process where different species can mate.

Jeanette Mucha, CEO, Chief Science Officer and Co-Founder of SCIBAC, gave this illuminating overview of how they design live biotherapeutics to target antibiotic resistant disease in the microbiome, how MERGE works, strain improvements, their investment needs and more, at ABLC Global 2018 in San Francisco

Prev1 of 21
Use your ← → (arrow) keys to browse

Print Friendly, PDF & Email

Category: 8-Slide Guide

Thank you for visting the Digest.